Weizhu Wu

机构：Ningbo University, Ningbo Medical Center Lihuili Hospital · ORCID：0000-0002-5064-0685

发表论文 12 篇 · 总被引 18 次 · h-index 2

代表论文

• Core-shell iron oxide-platinium@metal organic framework/epirubicin nanospheres: Synthesis, characterization and anti-breast cancer activity (2023 · Arabian Journal of Chemistry · 被引 11)
• Hsa_circ_0000129 drives tumor growth via sequestering miR‐485‐3p and upregulating SPIN1 in breast cancer (2022 · Journal of Biochemical and Molecular Toxicology · 被引 4)
• Biomimic colloidal self-assembly of epirubicin/ferric ion multi-enzyme delivery for synergistic photothermal therapy of metastatic triple-negative breast cancer (2026 · Colloids and Surfaces B Biointerfaces · 被引 1)
• Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A multicenter phase II trial (2024 · eLife · 被引 1)
• Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A multicenter phase II trial (2024 · eLife · 被引 1)
• The First NIR Fluorescent Probe for Bioimaging of Cystathionine-γ-lyase Activity in Living Cells and Xenograft Tumor Models (2026 · Analytical Chemistry)